Australia Secures Onshore Manufacturing Agreements For Two COVID-19 Vaccines
7 September 2020 A free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successful, following a $1.7 billion supply and production agreement between the Australian Government and pharmaceutical companies. Under the agreement,…
Opyl achieves major milestone with AI platform that forecasts COVID19 clinical trial outcomes
3 September 2020 Opyl’s technology improves clinical trials by identifying the drugs, vaccines, diagnostics or medical devices most likely to succeed Opyl is applying its platform towards COVID-19 therapeutic and vaccine programs in clinical studies to predict likelihood…
Working Together To Re-Open Victoria – Safely
31 August 2020 Via Premier of Victoria, Daniel Andrews. The Victorian Government will release its reopening roadmap this Sunday, 6 September, providing certainty and clarity to communities and businesses alike. Ahead of this release, the Government will commence…
Supporting The Next Generation Of Tech Startups – And Jobs
30 August 2020 Via Premier of Victoria, Daniel Andrews. Victorian Government funding to back the new generation of startup innovators will support programs for female entrepreneurs as well as aspiring founders from regional Victoria and Melbourne’s western suburbs.…
Crucial Medical Research Joins Coronavirus Fight
26 August 2020 Via Premier of Victoria, Daniel Andrews. Victoria’s world-leading medical researchers are making significant strides in the battle against coronavirus, with the Victorian Government providing support for projects on multiple fronts. The Government has invested more…
Azure Health Technology Limited commences first manufacturing run in the US for nutraceutical products
24 August 2020 Azure Health Technology Limited (AZT) today announced that it has commenced manufacturing the first batch of nutraceutical products for sale in the US, Australia and China. AZT’s wholly owned subsidiaries, Invictus BioPharma Ltd (based in…
New Deal Secures Potential COVID-19 Vaccine For Every Australian
20 August 2020 Release date: 19 August 2020 Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the Australian Government and UK-based drug company AstraZeneca. Under…
Securing The Future Of Regenerative Medicine In Victoria
Date posted: 18 August 2020 Release date: 10 August 2020 The Victorian Government is growing the state’s world-leading medical research sector, securing the retention of the national headquarters of the Centre for Commercialisation of Regenerative Medicine (CCRM) Australia. CCRM speeds up…
AAMRI OIS Report 2020 – Highlights from 12 Victorian Independent Medical Research Institutes
17 August 2020 Release date: 14 August 2020 The AAMRI Operational Infrastructure Support (OIS) Program is essential to the 12 Victorian independent medical research institutes it supports. In 2018–2019 the Victorian Government provided $34.5M to these institutes to cover…
COVID-19 vaccine and treatment manufacture and supply chain RFI
11 August 2020 Close date: 20 August 2020 In response to the COVID-19 pandemic, the Australian Government is working to seek early access to and delivery of safe and effective COVID-19 vaccines and treatments as soon as they…
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
6 August 2020 Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID‑19 vaccine with and without Matrix‑M™ adjuvant…
Premier’s statement on business restrictions – impacts for businesses
4 August 2020 Release date 3 August 2020 Yesterday Daniel Andrews, Premier of Victoria announced a series of business restrictions. These are in direct response to Victoria’s move to Stage 4 Restrictions in combating COVID-19 transmission. Read the…
